根据最新的财务报表(Form-10K),Getinge AB (publ) 的总资产为 $0,净损失为 $0
GNGBY 的关键财务比率是什么?
Getinge AB (publ) 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Getinge AB (publ) 的收入按细分市场或地理位置如何划分?
Getinge AB (publ) 最大收入来源是 Acute Care Therapies,在最近的收益报告中收入为 16,529,000,000。就地区而言, United States 是 Getinge AB (publ) 的主要市场,收入为 11,697,000,000。
Getinge AB (publ) 是否盈利?
不,根据最新的财务报表,Getinge AB (publ) 的净损失为 $0
Getinge AB (publ) 有负债吗?
不,Getinge AB (publ) 的负债为 0
Getinge AB (publ) 的流通股有多少?
Getinge AB (publ) 的总流通股为 0
关键数据
前收盘价
$20.66
开盘价
$20.94
当日区间
$20.94 - $21.15
52周范围
$18.7 - $24.67
交易量
200
平均成交量
4.3K
股息收益率
--
每股收益(TTM)
0.94
市值
$5.3B
什么是 Getinge AB?
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.